验证强直性脊柱炎长期有效运动管理:去中心化随机对照试验研究方案
这项去中心化随机对照试验将从广东省风湿免疫专科联盟纳入120例强直性脊柱炎患者,按1:1随机分为基于态度-社会影响-自我效能(ASE)模型的运动管理模式(EMM-ASE)干预组和常规管理对照组。干预组通过运动移动智能管理平台接受个体化、分阶段运动策略、实时反馈、社会支持及每两周一次网络直播运动课程。主要结局为国际体力活动问卷(IPAQ)测量的运动水平,次要结局包括BASFI、BASDAI、FSS、ASQoL及运动依从性,随访至6个月。
要点
- 拟纳入120例强直性脊柱炎患者,1:1随机分为EMM-ASE干预组与常规管理对照组。
- 主要结局为IPAQ测量的运动水平,随访基线、1、3、6个月。
- 干预组通过移动智能管理平台接受个体化分阶段运动策略及每两周网络直播运动课程。
核心结论
- 研究方案预期干预组在随访时IPAQ评分更高、BASFI评分更低,并在其他指标上表现更好,以证明EMM-ASE策略的优越性。
研究设计与样本
- 去中心化随机对照试验(D-RCT),计划从广东省风湿免疫专科联盟纳入120例强直性脊柱炎患者,按1:1随机分为EMM-ASE干预组和常规管理对照组。
- 干预组通过强直性脊柱炎运动移动智能管理平台接受个体化、分阶段运动策略,包括实时反馈、社会支持和每两周一次网络直播运动课程;对照组接受标准运动指导和患者支持小组服务。
- 主要结局为国际体力活动问卷(IPAQ)测量的运动水平;次要结局包括Bath强直性脊柱炎功能指数(BASFI)、Bath强直性脊柱炎疾病活动指数(BASDAI)、疲劳严重程度量表(FSS)、强直性脊柱炎生活质量量表(ASQoL)和运动依从性。
- 数据在基线、1、3、6个月收集;统计分析包括意向性治疗分析、混合线性模型、潜类别模型轨迹分析和敏感性分析。
- 研究方案于2025年5月12日在中国临床试验注册中心注册,注册号ChiCTR2500102260。
关键数值与推荐
- 主要结局为IPAQ测量的运动水平。
- 次要结局包括BASFI、BASDAI、FSS、ASQoL和运动依从性。
- 数据收集时间点为基线、1、3、6个月。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Ankylosing spondylitis (AS), a chronic inflammatory disease, leads to significant physical and psychosocial burdens due to progressive spinal rigidity and high disability rates. Although exercise is well-established as a key factor in delaying deformity and enhancing function, maintaining long-term adherence poses a significant hurdle. This study aims to validate the effectiveness of an Exercise Management Mode based on the Attitude-Social Influence-Self-Efficacy (ASE) model (EMM-ASE) in enhancing exercise behavior and clinical outcomes among AS patients. METHODS: This decentralized randomized controlled trial (D-RCT) will enroll 120 AS patients from the Guangdong Rheumatology and Immunology Specialty Alliance. Participants will be randomized 1:1 into an intervention group (EMM-ASE) or a control group (routine management). The intervention group receives personalized, stage-based exercise strategies via the AS Exercise Mobile Intelligent Management Platform, including real-time feedback, social support, and biweekly network-broadcasted exercise sessions. The control group receives standard exercise guidance and access to patient support groups. Primary outcomes are exercise level (measured by the International Physical Activity Questionnaire, IPAQ). Secondary outcomes include functional capacity (Bath Ankylosing Spondylitis Functional Index, BASFI), disease activity (Bath Ankylosing Spondylitis Disease Activity Index, BASDAI), fatigue severity (Fatigue Severity Scale, FSS), quality of life (Ankylosing Spondylitis Quality of Life, ASQoL), and exercise adherence. Data will be collected at baseline, 1, 3, and 6 months. Statistical analyses include intention-to-treat analysis using mixed linear models, trajectory analysis via latent class models, and sensitivity analyses. DISCUSSION: The intervention group in this D-RCT, which innovatively applies a mobile platform to AS exercise management, is expected to show more significant improvements in primary and secondary outcomes than the control group. Specifically, at follow-up points, it is anticipated that they will have higher IPAQ scores, lower BASFI scores, and better performance in other indicators. This design would prove the superiority of the EMM-ASE strategy, offering a new effective model for AS treatment. TRIAL REGISTRATION: The study protocol was registered with Chinese Clinical Trial Registry on 12 May 2025, https://www.chictr.org.cn/showproj.html?proj=272057 (registration number: ChiCTR2500102260).
引用
- Huang L, Pan Y, Tang X, et al. Validation of a long-term and effective physical exercise management for ankylosing spondylitis: study protocol for a decentralized randomized controlled trial. Trials. 2025. PMID: 41013808. doi:10.1186/s13063-025-09096-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。